Your partner in personalised medicine.

It’s well known that prevention is better than cure. And that’s our mantra at geneType. Our tests help develop personalised, preventative health plans for your patients. By integrating your patient’s clinical, familial and genetic data, we deliver a personalised score for their risk of serious conditions. What’s more, we help you interpret your patient’s results in the context of your local guidelines.

Available to Medical Practitioners

GeneType Multi Suite

A combination of geneType tests for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type 2 diabetes in a single test.

Know your patient’s risk of a serious disease to tailor a personalised prevention plan.

Request more information

Take the first step towards personalised, preventative healthcare

Knowing your patients’ personalised risk enables you to develop a health plan with them to reduce their risk of serious disease. Select from the tests below to take the first step to managing your patients’ risk.

Breast Cancer

Find out if your patients are at increased risk of developing breast cancer

Learn More

Colorectal Cancer

Find out if your patients are at increased risk of developing colorectal cancer

Learn More

Multi-test

Find out if your patients are at increased risk of developing a wide range of cancers as well as coronary artery disease and type 2 diabetes

Learn more

Mental Health

Find out which antidepressant and dose could maximise your patients’ response and minimise side effects

Coming Soon

Other Conditions

Find out if your patients are at increased risk of developing conditions such as glaucoma, melanoma or atrial fibrillation

Coming Soon

COVID-19 Severity

Find out if your patients are at risk of developing severe COVID-19 symptoms

Learn More

One report.
Actionable insights.

GeneType provides a comprehensive risk assessment report that will assist you in developing a personalised health plan for your patients.

Key features of a geneType report include:

Quick identification of your patient’s lifetime risk score and 5-, 8- or 10-year risk depending on the condition.
Interpretation of these risk scores in the context of your local guideline recommendations to assist with clinical decision making about screening and risk-reducing strategies.
A polygenic risk score: this score is based on genetic data and is integrated into the overall risk score. It is typically not included in traditional risk assessment models.

Sample patient report

Ordering geneType test kits is easy

Enter your contact information here, send us an email at support@genetype.com, or call us at 704.926.5700.

Review the relevant medical education information and speak with our Medical Affairs Team to answer any outstanding questions you may have.

Request collection kits for your clinic. Our team can walk you and your staff through our collection and test procedures to ensure we fit into your clinical workflow.

register as a provider

Scientific Advisory Board

To ensure our tests are of the highest clinical value, geneType has enlisted the experience and expertise of senior scientific and medical leaders from around the world. They help us tailor our tests to reflect the strongest scientific evidence. Together can advance the field. personalised, preventative health solutions.

Professor Jon Emery

MBBCh MA DPhil FRACGP MRCGP

Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne

Professor Finlay Macrae AO

MBBS, MD, FRACP, FRCP, AGAF MWGO

Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital

Dr. Ora K. Gordon

MD, MS, FACMG

Regional Medical Director, Center for Clinical Genetics & Genomics. Clinical Director, PSJH Population Health Genomics Program. Chair, Integrated Network Cancer Program, Professor of Genetics, St John Cancer Institute

Our Leadership & Advisory

A genetic counsellor
on your team.

A genetic counsellor is available to help your geneType patients understand the geneType test and interpret their results.

For medical practitioners who order geneType test, you and your patients have the option to speak with a genetic counsellor when their results are ready.

For patients who order through our telehealth partner, they need to speak with our genetic counsellor to have their results released.

Our goal is to support both medical practitioners and patients through this journey. This is not a test-and-forget approach.

If you have technical questions, or questions around a patient’s clinical report, our genetic counsellor and Medical Affairs Team is available to you.